Company Overview
Snapshot
Founded in January 2018 by Maya Ashkenazi (Otmazgin), MAOLAC operates with 11–50 employees. The company has raised $4.05 million across 4 funding rounds from 9 investors. In May 2022, OurCrowd led a Seed funding round for MAOLAC.
Business overview
MAOLAC is a Health Tech & Life Sciences company developing bio-functional proteins (BFPs) for integration into food, beverages, supplements, and cosmetic products. Its core technology, the proprietary Proteomics Discovery Platform (MAOreka), utilizes AI tools like NLP search algorithms and Web Scraping to identify functional protein combinations with high bio-similarity to human breast milk. These functional ingredients, coupled with a unique delivery system, aim to offer enhanced performance for indications such as anti-inflammation and gut health. The company targets the food tech, food processing, and pharma & medical biotechnology sectors, serving global markets with human-grade protein mixtures derived from dairy or plant-based sources.
Strategic signal
In May 2024, MAOLAC received the NutraIngredients Start-up Award 2024, signaling significant industry recognition for its innovative approach to bio-functional proteins. This award validates the company's scientific advancements and market potential within the nutrition and health sectors, suggesting a positive trajectory for product development and commercialization.
Log in to access full profile ›Company Intelligence Q&A
- What is MAOLAC's core technology?
- MAOLAC utilizes a proprietary Proteomics Discovery Platform (MAOreka) that leverages AI tools, including NLP search algorithms and web scraping technologies, to identify and enrich specific groups of functional proteins. This platform enables the development of bio-functional proteins with high bio-similarity to human breast milk.
- When was MAOLAC founded and by whom?
- MAOLAC was founded in January 2018 by Maya Ashkenazi (Otmazgin).
- What was a significant recent recognition for MAOLAC?
- In May 2024, MAOLAC won the NutraIngredients Start-up Award 2024, recognizing its innovative contributions to the industry.
- Which investors participated in MAOLAC's May 2022 funding round?
- In May 2022, OurCrowd led a Seed funding round for MAOLAC, with participation from theFoodTechLab.
- What is the primary application of MAOLAC's products?
- MAOLAC's Bio Functional Proteins (BFPs) are designed to be integrated into food, beverages, supplements, and cosmetic products, targeting specific health benefits such as gut support and anti-inflammatory activity.